Spots Global Cancer Trial Database for braf positive tumor
Every month we try and update this database with for braf positive tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
An Absorption, Distribution, Metabolism and Excretion (ADME) Study of Single Oral Dose [14C] GSK2118436 in Subjects With BRAF Mutant Solid Tumors | NCT01262963 | Cancer | GSK2118436 | 18 Years - | GlaxoSmithKline | |
An Absorption, Distribution, Metabolism and Excretion (ADME) Study of Single Oral Dose [14C] GSK2118436 in Subjects With BRAF Mutant Solid Tumors | NCT01262963 | Cancer | GSK2118436 | 18 Years - | GlaxoSmithKline | |
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors | NCT01340846 | Cancer | Warfarin Ketoconazole Gemfibrozil GSK2118436 150m... GSK2118436 75mg | 18 Years - | GlaxoSmithKline | |
An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive Tumor | NCT01231568 | Cancer | Regimen A Regimen B Regimen C Regimen D | 18 Years - | GlaxoSmithKline |